LifeStance Health Group Past Earnings Performance
Past criteria checks 0/6
LifeStance Health Group has been growing earnings at an average annual rate of 15.1%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 27% per year.
Key information
15.1%
Earnings growth rate
157.6%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 27.0% |
| Return on equity | -6.6% |
| Net Margin | -7.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Should You Think About Buying LifeStance Health Group, Inc. (NASDAQ:LFST) Now?
Dec 26
LifeStance Health Group (NASDAQ:LFST) Is Making Moderate Use Of Debt
Dec 05Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Nov 10Why Investors Shouldn't Be Surprised By LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S
Sep 26Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt
Sep 02LifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 11LifeStance Health Group, Inc.'s (NASDAQ:LFST) Intrinsic Value Is Potentially 63% Above Its Share Price
Jul 15With LifeStance Health Group, Inc. (NASDAQ:LFST) It Looks Like You'll Get What You Pay For
Jun 07LifeStance: Selloff Opens Buying Opportunity Thanks To Price/Value Dislocation
May 23LifeStance Health Group, Inc. (NASDAQ:LFST) Analysts Are Pretty Bullish On The Stock After Recent Results
May 12Why LifeStance Health Group, Inc. (NASDAQ:LFST) Could Be Worth Watching
May 06Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)
Mar 23LifeStance Health Group, Inc. (NASDAQ:LFST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50
Mar 02LifeStance Q4 Earnings Review: Monetizing Mental Health Virtually Is Problematic
Feb 29Does LifeStance Health Group (NASDAQ:LFST) Have A Healthy Balance Sheet?
Feb 28LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S Still Appears To Be Reasonable
Jan 23What Is LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Doing?
Jul 08Is LifeStance Health Group, Inc. (NASDAQ:LFST) Expensive For A Reason? A Look At Its Intrinsic Value
May 09Revenue & Expenses Breakdown
How LifeStance Health Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,206 | -95 | 351 | 0 |
| 30 Jun 24 | 1,156 | -151 | 346 | 0 |
| 31 Mar 24 | 1,104 | -173 | 348 | 0 |
| 31 Dec 23 | 1,056 | -186 | 343 | 0 |
| 30 Sep 23 | 1,004 | -188 | 346 | 0 |
| 30 Jun 23 | 959 | -164 | 348 | 0 |
| 31 Mar 23 | 909 | -187 | 355 | 0 |
| 31 Dec 22 | 860 | -216 | 373 | 0 |
| 30 Sep 22 | 820 | -277 | 414 | 0 |
| 30 Jun 22 | 776 | -360 | 504 | 0 |
| 31 Mar 22 | 727 | -361 | 495 | 0 |
| 31 Dec 21 | 668 | -344 | 431 | 0 |
| 30 Sep 21 | 596 | -515 | 331 | 0 |
| 30 Jun 21 | 524 | -397 | 185 | 0 |
| 31 Mar 21 | 447 | -331 | 113 | 0 |
| 31 Dec 20 | 377 | -286 | 88 | 0 |
| 31 Dec 19 | 213 | -59 | 48 | 0 |
Quality Earnings: LFST is currently unprofitable.
Growing Profit Margin: LFST is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LFST is unprofitable, but has reduced losses over the past 5 years at a rate of 15.1% per year.
Accelerating Growth: Unable to compare LFST's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LFST is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: LFST has a negative Return on Equity (-6.63%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 07:30 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LifeStance Health Group, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephanie Davis | Barclays |
| Jamie Perse | Goldman Sachs |
| Jamie Perse | Goldman Sachs |